Evidence Matters 2024

February 21-22, 2024

The annual two-day virtual summit for the global literature review community

Evidence Matters is a virtual two-day summit that brings together global leaders in the literature review community to learn, engage, and solve ever-evolving evidence-based research challenges. We celebrate the criticality of evidence-based research in generating trusted and actionable science that benefits all of humankind. We seek to connect with industry leaders, share best practices, and create new possibilities, with the goal of enabling and supporting greater levels of innovation across the entire literature review lifecycle.

Confirmed Speakers

Sepanta Fazaeli

Clinical Systems & Medical Data Lead, Stryker

Christa Goode

Worldwide Scientific Operations Director, Medical Writing at Johnson & Johnson

Rea Castro

Director of Medical Affairs at QuidelOrtho

Mike Klopfer

Clinical Development Scientist at Philips

Dr. David Chalyan

Clinical Development Director, Evidence Transformation and Medical Safety Officer at Philips IGTD

Tom Kokhuis

Clinical Analyst at Philips

Rajpal Singh

Engagement Manager, Health Economics and Outcomes Research at IQVIA

Michael Braun-Boghos

Senior Director Safety Strategy at Oracle

Kateryna Onishchenko

Director, Meta-Research, Health Economics Global HEOR at AbbVie

Nick Halfpenny

Director, Strategic Market Access Center of Excellence at OPEN Health

Steve Mallett

Senior Manager at Veramed

Suzanne McMullen

Senior Principal at Medlior

Maria Anitan, MD

Global Head of Pharmacovigilance and Drug Safety at Med Communications, Inc.

Remon van den Broek

Head of AI Strategy and Data Science at Adelphi Group

Julie Pritchard-Hedtke

Former Vice President – Medical Affairs and Global Education at Siemens Healthineers

Brian O'Rourke

President 2023-2024 at ISPOR

Alexandra Zuckermann

Research Analyst at Public Health Agency of Canada (PHAC)

Sean Griffing

Epidemiologist, Division of HIV and AIDS Prevention at Centers for Disease Control and Prevention (CDC)

Andrew Purchase

Director, Pharmacovigilance Specialized Services and UK QPPV at ICON

Richard Holborow BSc (Hons) MSCST RCCP

Global Head of Clinical Compliance for BSI Notified Body (NL) & BSI Approved Body (UK)

Tom Patten

Certification and Inspection Officer (IVD) at National Standards Authority of Ireland

Marianna Mastroroberto

Internal Clinical Expert at Kiwa Cermet Italia

Bassil Akra

Founder & CEO at AKRA Team GmbH

Candyce Hamel

Adjunct Professor, Senior Epidemiologist at Canadian Association of Radiologists

Amanda Steele

Director, Scientific Communications at Myriad Genetics

Marta Carnielli

Head of Certification IVD at TÜV SÜD

Rushdi Shams

Senior Machine Learning Engineer at DistillerSR

Mark Priatel

VP Software Engineering at DistillerSR

Peter O'Blenis

CEO at DistillerSR

Marc Eaglesham

Executive Vice President Sales at DistillerSR

Chris Wright

EVP Operations at DistillerSR

Alissa Epworth

Customer Success Manager at DistillerSR

Romney Adams

Learning Specialist at DistillerSR

Chia Lian

Customer Success Manager at DistillerSR

Agenda – Day 1: February 21, 2024

10:00am – 11:00am EST

Keynote session: Can AI Support Evidence Diversity?

Dr. David Chalyan, Clinical Development Director, Evidence Transformation and Medical Safety Officer at Philips IGTD, moderated by Peter O’Blenis, DistillerSR CEO

11:00 am – Noon EST

Industry Track: Customer Best Practices Breakout Sessions

Medical Devices/IVD
Driving MedTech Innovation Through AI-Enabled Integrated Evidence Management

Pharma

Are HEOR Professionals Ready for AI?

This best practice session will provide an overview of the current landscape of technology and machine-learning applications, as well as HTA requirements on systematic reviews to support global HTA submissions.

Pharmacovigilance

Leveraging AI for Post-Market Surveillance Adverse Event Literature Detection

This best practice session will examine how different governments, NGOs, and academic institutions approached literature reviews at the height of the pandemic. Topics include lessons learned and what should and could be done differently.

Guideline Development

Collaborative Evidence Synthesis Strategies for Rapid Guideline Development

This best practice session will examine automated approaches to literature review management that can streamline and ensure the accuracy of literature triage for pharmacovigilance.

Agenda – Day 2: February 22, 2024

10:00am – 11:00am EST

Keynote session: Shaping the Future of Healthcare: Innovations and Equity in HEOR

Brian O’Rourke, ISPOR President 2023-2024, moderated by Peter O’Blenis, DistillerSR CEO

11:00 am – Noon EST

Partner Track: Beyond the Hype: Trusting AI to Accelerate Research

ITEA Research Consortium

Applying Generative AI to Evidence Synthesis in Literature Reviews

Data Visualization
Creating Citation Reputation Index for Your SLR

Real-World Evidence (RWE):

Leveraging Literature Reviews to Drive your RWE Strategy

Medical Devices/IVD: Notified Body Roundtable

EU MDR/IVDR Certification Landscape: Trends, Challenges, and Strategizing for Success

This best practice session will examine automated approaches to literature review management that can streamline and ensure the accuracy of literature triage for pharmacovigilance.